AI-generated · cited to primary sources · not investment advice
Ganesha Ecosphe. (514167) Nov 2025 Filing Analysis
Does management do what it says?
The company has successfully operationalized the rPET facilities and reached the target capacity of 42,000 TPA for rPET granules at Warangal. (1 met across 1 tracked commitment)
“Increasing rPET granules capacities by 90,000 MTPA to meet the growing demand”
Management confirmed that demand and consumption from F&B players (B2B segment) has seen an uptake compared to the previous quarter, starting from January. (3 met, 2 revised across 5 tracked commitments)
“We are getting the commitments from our existing buyers to start deliveries from January, 2026 onwards.”
Management admitted that the first half of FY26 fell short of expectations, with Q2 specifically seeing compressed EBITDA margins (6.1%) and negative net profits, making the full-year target of surpassing FY25 unlikely. (4 missed, 1 met across 5 tracked commitments)
“Backed by firm sale prices and healthy order inflows, we anticipate an improvement in EBITDA margins to the 7–9% range during the December and March quarters in our legacy business.”
Greenfield expansion project timeline and estimated capex. — target: INR 500 crores (+4 more commitments)
“So greenfield expansion plan... it is expected to be operational by end of this next financial year. So expected capex is about INR500 crores for that project.”
See the full cited Management analysis of Ganesha Ecosphe.
Where does growth come from?
The legacy business showed strong volume growth of 20.9% in Q2 FY26 compared to the previous quarter, indicating a recovery in core operations. (3 accelerating, 2 reversing across 5 signals)
“Achieved sales volume of 39,132 MT- increase of 16.3% (20.9% in legacy business & 4.7% in subsidiary business)”
See the full cited Future Growth analysis of Ganesha Ecosphe.
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.